Xbrane Biopharma AB (publ) (XBRANE.ST)

SEK 0.16

(-3.53%)

Eps Summary of Xbrane Biopharma AB (publ)

  • Xbrane Biopharma AB (publ)'s latest annual eps in 2023 was -1.27 SEK , down -98.7% from previous year.
  • Xbrane Biopharma AB (publ)'s latest quarterly eps in 2024 Q2 was -0.05 SEK , up 83.33% from previous quarter.
  • Xbrane Biopharma AB (publ) reported an annual eps of -0.77 SEK in 2022, up 17.39% from previous year.
  • Xbrane Biopharma AB (publ) reported an annual eps of -0.90 SEK in 2021, up 35.21% from previous year.
  • Xbrane Biopharma AB (publ) reported a quarterly eps of -0.05 SEK for 2024 Q2, up 83.33% from previous quarter.
  • Xbrane Biopharma AB (publ) reported a quarterly eps of -0.03 SEK for 2024 Q3, up 41.0% from previous quarter.

Annual Eps Chart of Xbrane Biopharma AB (publ) (2023 - 2012)

Historical Annual Eps of Xbrane Biopharma AB (publ) (2023 - 2012)

Year Eps Eps Growth
2023 -1.27 SEK -98.7%
2022 -0.77 SEK 17.39%
2021 -0.90 SEK 35.21%
2020 -1.41 SEK 16.47%
2019 -1.90 SEK 15.84%
2018 -0.23 SEK 74.27%
2017 -0.89 SEK -12.14%
2016 -0.76 SEK -35.14%
2015 -0.57 SEK -375.23%
2014 -0.12 SEK -21.11%
2013 -0.92 SEK -153.52%
2012 -0.35 SEK 0.0%

Peer Eps Comparison of Xbrane Biopharma AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -130.909%
Ziccum AB (publ) -1.54 SEK 17.532%
Modus Therapeutics Holding AB (publ) -1.01 SEK -25.743%
BioArctic AB (publ) 2.60 SEK 148.846%
Sprint Bioscience AB (publ) -0.01 SEK -20058.73%
Mendus AB (publ) -4.40 SEK 71.136%
Genovis AB (publ.) 0.94 SEK 235.106%
Intervacc AB (publ) -1.69 SEK 24.852%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -477.273%
Active Biotech AB (publ) -0.17 SEK -647.059%
Magle Chemoswed Holding AB (publ) 1.13 SEK 212.389%
Bio-Works Technologies AB (publ) -1.57 SEK 19.108%
Aptahem AB (publ) -0.05 SEK -2529.4%
Vicore Pharma Holding AB (publ) -3.22 SEK 60.559%
Kancera AB (publ) -0.80 SEK -58.75%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 87.236%
Fluicell AB (publ) -0.24 SEK -429.167%
Saniona AB (publ) -1.29 SEK 1.55%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -568.421%
Biovica International AB (publ) -2.14 SEK 40.654%
Spago Nanomedical AB (publ) -0.43 SEK -195.349%
AcouSort AB (publ) -1.29 SEK 1.55%
Xintela AB (publ) -0.13 SEK -876.923%
Abliva AB (publ) -0.09 SEK -1304.867%
Egetis Therapeutics AB (publ) -1.27 SEK -0.0%
Karolinska Development AB (publ) 0.02 SEK 6450.0%
OncoZenge AB (publ) -1.36 SEK 6.618%
Amniotics AB (publ) -0.01 SEK -11445.455%
2cureX AB (publ) -1.85 SEK 31.351%
CombiGene AB (publ) -1.80 SEK 29.444%
Asarina Pharma AB (publ) -0.57 SEK -122.807%
Calliditas Therapeutics AB (publ) -8.69 SEK 85.386%
Camurus AB (publ) 7.78 SEK 116.324%
Corline Biomedical AB -0.08 SEK -1408.314%
IRLAB Therapeutics AB (publ) -3.43 SEK 62.974%
Isofol Medical AB (publ) -0.23 SEK -452.174%
I-Tech AB 1.70 SEK 174.706%
Hansa Biopharma AB (publ) -15.83 SEK 91.977%
Cyxone AB (publ) -0.22 SEK -477.273%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 35.859%
Biosergen AB -0.60 SEK -111.667%
Cantargia AB (publ) -1.65 SEK 23.03%
NextCell Pharma AB -1.03 SEK -23.301%
Xspray Pharma AB (publ) -6.76 SEK 81.213%
Elicera Therapeutics AB (publ) -0.83 SEK -53.012%
Nanologica AB (publ) -2.05 SEK 38.049%
SynAct Pharma AB -6.64 SEK 80.873%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -388.462%
Stayble Therapeutics AB (publ) -0.92 SEK -38.043%
LIDDS AB (publ) -0.63 SEK -101.587%
Lipum AB (publ) -4.45 SEK 71.461%
BioInvent International AB (publ) -5.02 SEK 74.701%
Alzinova AB (publ) -0.41 SEK -209.756%
Oncopeptides AB (publ) -1.96 SEK 35.204%
Pila Pharma AB (publ) -0.47 SEK -170.213%
Guard Therapeutics International AB (publ) -11.26 SEK 88.721%
Scandinavian ChemoTech AB (publ) -1.13 SEK -12.389%
Simris Alg AB (publ) -0.16 SEK -693.75%
Diamyd Medical AB (publ) -1.60 SEK 20.625%
Ascelia Pharma AB (publ) -3.24 SEK 60.802%
Diagonal Bio AB (publ) -0.32 SEK -296.875%